Strategies are required to strictly avoid re-exposure of patients to drugs which carry an increased risk of inducing a dangerous reaction, whilst minimising the avoidance of drugs which are of minimal risk or allowing the use of low-risk drugs where the benefits may be significant.
← all excerpts
Highlights and recent developments in allergic diseases in EAACI journals (2019).
1
—
—